# Comparative Effectiveness Study for Bipolar Disorder

> **NCT01331304** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 482 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT01331304
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-09
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331304, "Comparative Effectiveness Study for Bipolar Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01331304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*